Publication | Closed Access
LBA56 ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC)
17
Citations
0
References
2020
Year
MedicineBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyLba56 Orient-12RadiologyHealth Sciences
No additional data available for this publication yet. Check back later!